NuVasive PE Ratio 2006-2019 | NUVA

Current and historical p/e ratio for NuVasive (NUVA) from 2006 to 2019. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. NuVasive PE ratio as of September 18, 2019 is 27.09.
NuVasive PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2019-09-18 65.00 65.00
2019-06-30 58.54 $1.00 58.54
2019-03-31 56.79 $0.93 61.06
2018-12-31 49.56 $0.22 225.27
2018-09-30 70.98 $0.45 157.73
2018-06-30 52.12 $0.79 65.97
2018-03-31 52.21 $0.79 66.09
2017-12-31 58.49 $1.54 37.98
2017-09-30 55.46 $1.19 46.61
2017-06-30 76.92 $0.62 124.06
2017-03-31 74.68 $0.97 76.99
2016-12-31 67.36 $0.58 116.14
2016-09-30 66.66 $0.69 96.61
2016-06-30 59.72 $0.86 69.44
2016-03-31 48.65 $0.49 99.29
2015-12-31 54.11 $1.27 42.61
2015-09-30 48.22 $1.20 40.18
2015-06-30 47.38 $0.92 51.50
2015-03-31 45.99 $0.63 73.00
2014-12-31 47.16 $-0.38 0.00
2014-09-30 34.87 $-0.40 0.00
2014-06-30 35.57 $-0.20 0.00
2014-03-31 38.41 $-0.26 0.00
2013-12-31 32.33 $0.16 202.06
2013-09-30 24.49 $-0.03 0.00
2013-06-30 24.79 $-0.14 0.00
2013-03-31 21.31 $0.07 304.43
2012-12-31 15.46 $0.07 220.86
2012-09-30 22.91 $-0.11 0.00
2012-06-30 25.36 $-1.85 0.00
2012-03-31 16.84 $-1.78 0.00
2011-12-31 12.59 $-1.74 0.00
2011-09-30 17.06 $-0.11 0.00
2011-06-30 32.88 $1.79 18.37
2011-03-31 25.32 $1.83 13.84
2010-12-31 25.65 $1.80 14.25
2010-09-30 35.14 $0.47 74.77
2010-06-30 35.46 $0.39 90.92
2010-03-31 45.20 $0.29 155.86
2009-12-31 31.98 $0.14 228.43
2009-09-30 41.76 $0.18 232.00
2009-06-30 44.60 $-0.59 0.00
2009-03-31 31.38 $-0.67 0.00
2008-12-31 34.65 $-0.77 0.00
2008-09-30 49.33 $-0.90 0.00
2008-06-30 44.66 $-0.33 0.00
2008-03-31 34.51 $-0.42 0.00
2007-12-31 39.52 $-0.33 0.00
2007-09-30 35.93 $-0.38 0.00
2007-06-30 27.01 $-0.87 0.00
2007-03-31 23.75 $-1.33 0.00
2006-12-31 23.10 $-1.47 0.00
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $3.399B $1.102B
NuVasive, Inc. is transforming spine surgery and beyond with minimally invasive, procedurally-integrated solutions designed to deliver reproducible and clinically-proven surgical outcomes. The Company's portfolio includes access instruments, implantable hardware, biologics, and software systems for surgical planning, navigation and imaging solutions, magnetically adjustable implant systems for spine and orthopedics, and intraoperative monitoring service offerings.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $147.719B 27.77
Medtronic (MDT) Ireland $146.698B 20.59
Stryker (SYK) United States $81.704B 28.25
Boston Scientific (BSX) United States $58.951B 28.59
Baxter (BAX) United States $44.709B 27.11
EssilorLuxottica Societe Anonyme (ESLOY) France $31.891B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.506B 18.24
Coloplast (CLPBY) Denmark $25.510B 40.72
Lonza Group Ag (LZAGY) Switzerland $25.282B 0.00
Terumo (TRUMY) Japan $22.900B 26.33
Smith & Nephew SNATS (SNN) United Kingdom $20.809B 0.00
ResMed (RMD) United States $19.242B 36.69
Sunny Optical Technology (SNPTF) China $16.157B 0.00
Bio-Rad Laboratories (BIO) United States $10.056B 53.91
Canopy Growth (CGC) Canada $9.869B 0.00
Insulet (PODD) United States $8.744B 518.11
Perrigo (PRGO) Ireland $7.581B 13.97
William Demant Holdings (WILYY) Denmark $7.386B 0.00
Hill-Rom Holdings (HRC) United States $6.929B 20.66
Haemonetics (HAE) United States $6.450B 48.68
GN STORE NORD (GNNDY) Denmark $5.570B 28.78
Aurora Cannabis (ACB) Canada $5.377B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $4.252B 0.00
Neogen (NEOG) United States $4.127B 68.52
ICU Medical (ICUI) United States $3.395B 22.02
Hutchison China MediTech (HCM) China $2.815B 0.00
Quidel (QDEL) United States $2.690B 26.71
Agios Pharmaceuticals (AGIO) United States $2.149B 0.00
National Vision Holdings (EYE) United States $2.115B 45.66
Cardiovascular Systems (CSII) United States $1.821B 0.00
Aphria (APHA) $1.564B 0.00
VAREX IMAGING (VREX) United States $1.108B 25.54
AtriCure (ATRC) United States $1.008B 0.00
Lantheus Holdings (LNTH) United States $0.984B 25.88
Omeros (OMER) United States $0.939B 0.00
Phibro Animal Health (PAHC) United States $0.903B 14.68
Eagle Pharmaceuticals (EGRX) United States $0.808B 20.61
NanoString Technologies (NSTG) United States $0.783B 0.00
Cerus (CERS) United States $0.741B 0.00
PetIQ (PETQ) United States $0.721B 17.04
LeMaitre Vascular (LMAT) United States $0.710B 42.06
Quanterix (QTRX) United States $0.654B 0.00
MacroGenics (MGNX) United States $0.642B 0.00
Surmodics (SRDX) United States $0.630B 119.69
TG Therapeutics (TGTX) United States $0.614B 0.00
OraSure Technologies (OSUR) United States $0.467B 21.60
Meridian Bioscience (VIVO) United States $0.425B 13.27
BioLife Solutions (BLFS) United States $0.399B 131.13
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.385B 0.00
Utah Medical Products (UTMD) United States $0.369B 27.04
Owens & Minor (OMI) United States $0.367B 11.00
United Health Products (UEEC) United States $0.309B 0.00
Zynex (ZYXI) United States $0.305B 32.41
Bovie Medical (APYX) United States $0.243B 0.00
Rockwell Medical (RMTI) United States $0.211B 0.00
Cytosorbents (CTSO) United States $0.179B 0.00
Vapotherm (VAPO) United States $0.173B 0.00
Fonar (FONR) United States $0.147B 10.43
Chimerix (CMRX) United States $0.145B 0.00
Female Health (VERU) United States $0.124B 0.00
Chembio Diagnostics (CEMI) United States $0.121B 0.00
InfuSystems Holdings (INFU) United States $0.105B 0.00
United-Guardian (UG) United States $0.087B 20.60
MRI Interventions (MRIC) United States $0.067B 0.00
Nephros (NEPH) United States $0.063B 0.00
Surface Oncology (SURF) United States $0.057B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.055B 0.00
ImmuCell (ICCC) United States $0.039B 0.00
Trinity Biotech (TRIB) Ireland $0.034B 0.00
Senestech (SNES) United States $0.026B 0.00
GUARDION HEALTH (GHSI) United States $0.017B 0.00
Myomo (MYO) United States $0.013B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.012B 0.00
Capricor Therapeutics (CAPR) United States $0.012B 0.00
Valeritas Holdings (VLRX) United States $0.009B 0.00
Akers Biosciences Inc (AKER) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00